ELOCOM CREAM

Indications

Approved Uses

Relief of the inflammatory and pruritic manifestations of corticosteroid‑responsive dermatoses (e.g., atopic dermatitis/eczema and psoriasis).

Off-Label Uses

Off-label examples: localized vitiligo (adjunct), alopecia areata (limited areas), lichen planus (cutaneous), and pediatric phimosis (short course under specialist direction).

Dosage & Administration

Dosing by Condition

Corticosteroid‑responsive dermatoses (including atopic dermatitis and psoriasis): apply a thin film to affected areas once daily; reassess if inadequate response within ~2 weeks and limit duration especially on sensitive sites.

Initial Dose

Apply a thin film to the affected skin areas once daily.

Maintenance Dose

Apply once daily; reassess after 2-3 weeks; use the lowest effective frequency for maintenance

Maximum Dose

Apply a thin layer once daily; no fixed gram/week maximum is established in standard labeling-use the lowest effective amount and avoid large-area/prolonged use (especially face/intertriginous areas).

Children's Dosage

Children 2 years and older: Apply thin layer to affected area once daily for up to 3 weeks; not recommended in children under 2 years; use the smallest effective amount and avoid prolonged use due to higher surface area-to-body weight ratio increasing systemic absorption risk

Dose Adjustment Notes

Use the lowest effective amount once daily; when control is achieved, taper by reducing frequency (e.g., every other day/2-3 times weekly) or step down to a lower-potency steroid; reassess if no improvement within ~2 weeks; avoid prolonged continuous use, large surface areas, face/groin/axillae, and occlusion unless directed.

How to Take

For topical use only: apply a thin layer/film to affected skin once daily and rub in gently; wash hands after application (and before if hands are contaminated); avoid eyes, mouth, and other mucous membranes; do not use on broken/infected skin unless directed; do not cover with occlusive dressings/bandages unless prescribed; use the minimum amount for the shortest duration and avoid unnecessary application to surrounding normal skin.

Side Effects

Common Side Effects

Application-site burning/stinging/itching/irritation, dryness, erythema; with prolonged or extensive use: skin atrophy, striae, telangiectasia, hypopigmentation, acneiform eruptions/folliculitis, hypertrichosis, perioral dermatitis, and secondary infection.

Side Effect Frequency

Common: application-site burning/stinging, pruritus/irritation, dryness. Uncommon: folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, hypertrichosis, contact dermatitis, skin atrophy/striae, miliaria (risk increases with potency, duration, occlusion, and thin skin areas). Rare: HPA-axis suppression/Cushingoid effects, hyperglycemia, and ocular effects (glaucoma/cataract) particularly with periocular use or prolonged/high-exposure use.

Safety & Warnings

Contraindications

Hypersensitivity to mometasone furoate or any excipient; rosacea; perioral dermatitis; and use on untreated bacterial, viral (e.g., herpes simplex/varicella/vaccinia), fungal, or parasitic skin infections.

Warnings & Precautions

Avoid eyes/mucous membranes and not for ophthalmic use; avoid occlusion unless directed; use lowest effective amount and limit duration/area (extra caution on face, groin, axillae, and in children); do not use on untreated infections (treat infection first/with appropriate antimicrobials); discontinue if irritation/sensitization occurs; consider tapering after prolonged extensive use and monitor children for systemic effects.

Age Restriction

Not recommended for children under 2 years of age.

Drug Interactions

Drug Interactions

No formal interaction studies; clinically relevant interactions are mainly additive systemic corticosteroid effects with concurrent topical/systemic steroids and increased absorption with occlusive dressings (CYP3A4 inhibitor interactions are unlikely unless significant systemic absorption occurs).

Interaction Severity

MODERATE: Occlusive dressings or large-area/prolonged use (increases systemic absorption and HPA-axis suppression risk); MODERATE (theoretical/rare): strong CYP3A4 inhibitors if significant systemic absorption occurs; MINOR: concurrent use of other corticosteroids (additive local/systemic effects).

Food Interaction

No clinically relevant food interactions.

Special Populations

Children

Children 2 years and older: Apply thin layer to affected area once daily for up to 3 weeks; not recommended in children under 2 years; use the smallest effective amount and avoid prolonged use due to higher surface area-to-body weight ratio increasing systemic absorption risk

Kidney Impairment

No adjustment needed

Storage & Patient Advice

Stopping the Medicine

Discontinue when control is achieved; if used for prolonged periods or on large areas, taper (reduce frequency/potency) rather than stopping abruptly.

Overdose

Excessive/prolonged topical use can cause local adverse effects and systemic corticosteroid effects (HPA-axis suppression/Cushingoid features); management is to stop or taper and provide supportive care, assessing adrenal function if symptomatic; accidental ingestion is usually low risk but warrants medical advice if large amount or symptoms.

Patient Counseling

Apply a thin layer to affected skin once daily and rub in gently; use the smallest amount for the shortest duration needed. Avoid eyes, mouth, and mucous membranes; avoid face, groin, and axillae unless specifically prescribed and for short courses. Do not apply to broken skin or untreated infection; seek medical advice if infection is present or develops. Do not occlude (bandage/plastic wrap) unless directed. Wash hands after application unless treating hands. Stop and contact your prescriber if significant irritation occurs or if not improving within ~2 weeks (or as directed). Risk with prolonged/large-area use: skin atrophy/striae and possible systemic corticosteroid effects (HPA-axis suppression), especially in children. Store below 30°C.

Monitoring Requirements

Monitor clinical response and local adverse effects (atrophy, striae, infection); consider evaluation for HPA-axis suppression if used on large areas, for prolonged periods, under occlusion, on thin skin, or in children; in pediatrics, monitor for growth effects with prolonged/high-exposure use.

Pharmacology

Mechanism of Action

Topical glucocorticoid: binds intracellular glucocorticoid receptors to alter gene transcription, inducing lipocortins that inhibit phospholipase A2 and downstream prostaglandin/leukotriene production, producing anti-inflammatory, antipruritic, and vasoconstrictive effects.

Duration of Effect

Approximately 24 hours (supports once‑daily application).

Bioavailability

Systemic absorption after topical use is low (minimal) on intact, non-occluded skin, but increases with occlusion, damaged/inflamed skin, prolonged use, large surface area, and in children.

Product Information

Available Dosage Forms

Cream

Generic Availability

Yes

Skin Condition

Eczema, Psoriasis

Steroid Potency

Medium potency

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.